LONG-TERM SAFETY IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB. SINGLE INSTITUTION ANALYSIS AFTER A MEDIAN FOLLOW-UP OF 9 YEARS
HAEMATOLOGICA(2017)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined